Author:
Yousefnia Hassan,Jalilian Amir Reza,Zolghadri Samaneh,Mirzaei Alireza,Bahrami-Samani Ali,Mirzaii Mohammad,Ghannadi Mohammad
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry
Reference11 articles.
1. Rajendran JG, Eary JF, Bensinger W, Durack LD, Vernon C, Fritzberg A (2002) High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation. J Nucl Med 43:1383–1390
2. Bayouth JE, Macey DJ, Kasi LP (1995) Pharmacokinetics, dosimetry and toxicity of Holmium-166 DOTMP for bone marrow ablation in multiple myeloma. J Nucl Med 36:730–737
3. Simón J, Frank RK, Crump DK, Erwin WD, Ueno NT, Wendt RE 3rd (2012) A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical. Nucl Med Biol 39(6):770–776
4. Hassfjell SP, Bruland OS, Hoff P (1997) 212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy. Nucl Med Biol 24(3):231–237
5. Hassfjell S, Ingebrigtsen K, Bruland ØS (2001) Synthesis, purification and biodistribution of (205)Bi-DOTMP, visualizing bone deposition patterns with autoradiography. Nucl Med Biol 28(4):425–433
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献